Note: Ingredients listed on restricted chemical lists
EC/CAS
208-534-8/532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
>=60-<80
General Information
Version
3.2
Revision date
2025-03-03
Product name
Sika Injection-307 (B) Part B
1.2.1 Relevant identified uses
Sealing system, For professional users only
supplier name
Sika Norge AS
Emergency telephone
22 59 13 00
Icons in SDS
Company Information
company name
Sika Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
kundeservice@no.sika.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H319, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breath- ing difficulties if inhaled.
Prevention
P261 Avoid breathing dust. P280 Wear protective gloves/ eye protection/ face protection. P284 In case of inadequate ventilation wear respir- atory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Hazardous Ingredients
disodium peroxodisulphate
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have en- docrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regula- tion (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
